These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 24041717)

  • 1. Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review.
    Buoli M; Serati M; Altamura AC
    J Affect Disord; 2014 Jan; 152-154():12-8. PubMed ID: 24041717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
    Woodward TC; Tafesse E; Quon P; Lazarus A
    Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011.
    Hooshmand F; Miller S; Dore J; Wang PW; Hill SJ; Portillo N; Ketter TA
    J Affect Disord; 2014 Feb; 155():283-7. PubMed ID: 24314912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of atypical antipsychotics in bipolar disorder.
    Ehret MJ; Levin GM
    Pharmacotherapy; 2006 Aug; 26(8):1134-47. PubMed ID: 16863489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance.
    de Bartolomeis A; Perugi G
    Expert Opin Pharmacother; 2012 Oct; 13(14):2027-36. PubMed ID: 22946707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the treatment of bipolar depression.
    Azorin JM; Kaladjian A
    Expert Opin Pharmacother; 2009 Feb; 10(2):161-72. PubMed ID: 19236191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotics: newer options for mania and maintenance therapy.
    Vieta E; Goikolea JM
    Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
    Perlis RH
    Am J Manag Care; 2007 Nov; 13(7 Suppl):S178-88. PubMed ID: 18041879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A typical mood stabilizers: a "typical role for atypical antipsychotics.
    Malhi GS; Berk M; Bourin M; Ivanovski B; Dodd S; Lagopoulos J; Mitchell PB
    Acta Psychiatr Scand Suppl; 2005; (426):29-38. PubMed ID: 16104066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine.
    Kreys TJ; Fabian TJ; Saul MI; Haskett R; Coley KC
    J Psychiatr Pract; 2013 Jul; 19(4):288-95. PubMed ID: 23852103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New treatments for bipolar disorder: the role of atypical neuroleptic agents.
    Ghaemi SN
    J Clin Psychiatry; 2000; 61 Suppl 14():33-42. PubMed ID: 11154015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
    Danileviciūte V
    Medicina (Kaunas); 2002; 38(11):1057-65. PubMed ID: 12532717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
    Taylor DM; Cornelius V; Smith L; Young AH
    Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
    Goikolea JM; Colom F; Torres I; Capapey J; Valentí M; Undurraga J; Grande I; Sanchez-Moreno J; Vieta E
    J Affect Disord; 2013 Jan; 144(3):191-8. PubMed ID: 23089129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
    Miller DS; Yatham LN; Lam RW
    J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for atypical antipsychotics in bipolar disorder.
    Shattell M; Keltner NL
    Perspect Psychiatr Care; 2004; 40(1):34-8. PubMed ID: 15147051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine for bipolar depression: a systematic review and meta-analysis.
    Chiesa A; Chierzi F; De Ronchi D; Serretti A
    Int Clin Psychopharmacol; 2012 Mar; 27(2):76-90. PubMed ID: 22107783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
    Lin CY; Tsai GE; Wang HS; Wu YH; Chiou CC; Wu VY; Lane HY
    J Clin Psychiatry; 2014 Sep; 75(9):e924-31. PubMed ID: 25295435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
    Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
    J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.